Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Altered myocardial force-frequency relation in human heart failure.
|
Circulation
|
1992
|
3.12
|
2
|
Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy.
|
Circulation
|
1995
|
2.27
|
3
|
Endothelin-1 plasma levels are not elevated in patients with obstructive sleep apnoea.
|
Eur Respir J
|
2000
|
2.15
|
4
|
Angiotensin II blockers in obstructive pulmonary disease: a randomised controlled trial.
|
Eur Respir J
|
2006
|
2.07
|
5
|
Gene expression of the cardiac Na(+)-Ca2+ exchanger in end-stage human heart failure.
|
Circ Res
|
1994
|
2.04
|
6
|
Protection of human left ventricular myocardium from cutting injury with 2,3-butanedione monoxime.
|
Circ Res
|
1989
|
1.98
|
7
|
Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium.
|
Circ Res
|
1999
|
1.87
|
8
|
Alterations in intracellular calcium handling associated with the inverse force-frequency relation in human dilated cardiomyopathy.
|
Circulation
|
1995
|
1.86
|
9
|
Heterogeneous transmural gene expression of calcium-handling proteins and natriuretic peptides in the failing human heart.
|
Cardiovasc Res
|
1999
|
1.67
|
10
|
The effect of myosin light chain 2 dephosphorylation on Ca2+ -sensitivity of force is enhanced in failing human hearts.
|
Cardiovasc Res
|
2003
|
1.59
|
11
|
Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium.
|
Cardiovasc Res
|
2000
|
1.57
|
12
|
Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling.
|
J Clin Invest
|
1996
|
1.56
|
13
|
Marked sympathetic activation in patients with chronic respiratory failure.
|
Am J Respir Crit Care Med
|
2001
|
1.45
|
14
|
Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure.
|
J Am Coll Cardiol
|
2000
|
1.43
|
15
|
Importance of sympathetic activation for the expression of Na+-Ca2+ exchanger in end-stage failing human myocardium.
|
Eur Heart J
|
2002
|
1.43
|
16
|
Long-term clinical experience with the EGM width detection criterion for differentiation of supraventricular and ventricular tachycardia in patients with implantable cardioverter defibrillators.
|
Pacing Clin Electrophysiol
|
2000
|
1.38
|
17
|
Slow breathing reduces sympathoexcitation in COPD.
|
Eur Respir J
|
2008
|
1.28
|
18
|
Association of glucose metabolism with diastolic function along the diabetic continuum.
|
Diabetologia
|
2010
|
1.23
|
19
|
Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility.
|
Circ Res
|
2001
|
1.21
|
20
|
Gene expression of antioxidative enzymes in the human heart: increased expression of catalase in the end-stage failing heart.
|
Circulation
|
2000
|
1.14
|
21
|
Existence of the Frank-Starling mechanism in the failing human heart. Investigations on the organ, tissue, and sarcomere levels.
|
Circulation
|
1996
|
1.12
|
22
|
Frequency-dependence of myocardial energetics in failing human myocardium as quantified by a new method for the measurement of oxygen consumption in muscle strip preparations.
|
J Mol Cell Cardiol
|
1998
|
1.11
|
23
|
Preservation of contractile characteristics of human myocardium in multi-day cell culture.
|
J Mol Cell Cardiol
|
1999
|
1.09
|
24
|
Downregulation of the Na(+)-creatine cotransporter in failing human myocardium and in experimental heart failure.
|
Circulation
|
1999
|
1.05
|
25
|
Impaired contractile performance of cultured rabbit ventricular myocytes after adenoviral gene transfer of Na(+)-Ca(2+) exchanger.
|
Circ Res
|
2000
|
1.03
|
26
|
Expression, activity and functional significance of inducible nitric oxide synthase in the failing human heart.
|
J Am Coll Cardiol
|
1998
|
1.02
|
27
|
Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium.
|
Circulation
|
1999
|
0.99
|
28
|
The trabecula culture system: a novel technique to study contractile parameters over a multiday time period.
|
Am J Physiol
|
1998
|
0.99
|
29
|
Haemodynamic effects of intracoronary pyruvate in patients with congestive heart failure: an open study.
|
Lancet
|
1999
|
0.98
|
30
|
Over-expression of FK506-binding protein FKBP12.6 alters excitation-contraction coupling in adult rabbit cardiomyocytes.
|
J Physiol
|
2004
|
0.97
|
31
|
Influence of mild hypothermia on myocardial contractility and circulatory function.
|
Basic Res Cardiol
|
2001
|
0.96
|
32
|
The influence of cardiovascular and antiinflammatory drugs on thiazide-induced hemodynamic and saluretic effects.
|
Eur J Clin Pharmacol
|
2006
|
0.95
|
33
|
Pyruvate potentiates inotropic effects of isoproterenol and Ca(2+) in rabbit cardiac muscle preparations.
|
Am J Physiol Heart Circ Physiol
|
2000
|
0.91
|
34
|
Sarcoplasmic reticulum proteins in heart failure.
|
Ann N Y Acad Sci
|
1998
|
0.90
|
35
|
Short term effect of continuous positive airway pressure on muscle sympathetic nerve activity in patients with chronic heart failure.
|
Heart
|
2001
|
0.89
|
36
|
A mechanistic analysis of the force-frequency relation in non-failing and progressively failing human myocardium.
|
Basic Res Cardiol
|
1998
|
0.89
|
37
|
Load-dependent induction of apoptosis in multicellular myocardial preparations.
|
Am J Physiol Heart Circ Physiol
|
2002
|
0.89
|
38
|
Transient and sustained impacts of hydroxyl radicals on sarcoplasmic reticulum function: protective effects of nebivolol.
|
Eur J Pharmacol
|
1999
|
0.88
|
39
|
Angiotensin I and II exert inotropic effects in atrial but not in ventricular human myocardium. An in vitro study under physiological experimental conditions.
|
Circulation
|
1993
|
0.87
|
40
|
Effects of different proton pump inhibitors on cardiac contractility in isolated human failing myocardium.
|
J Cardiovasc Surg (Torino)
|
2011
|
0.86
|
41
|
Modulation of myothermal economy of isometric force generation by positive inotropic interventions in the guinea pig myocardium.
|
Cardioscience
|
1990
|
0.85
|
42
|
Influence of endothelin 1 on human atrial myocardium--myocardial function and subcellular pathways.
|
Basic Res Cardiol
|
1996
|
0.85
|
43
|
Myosin light chain composition in non-failing donor and end-stage failing human ventricular myocardium.
|
Adv Exp Med Biol
|
2003
|
0.85
|
44
|
Alterations of the force-frequency relationship in the failing human heart depend on the underlying cardiac disease.
|
Basic Res Cardiol
|
1992
|
0.84
|
45
|
Levosimendan improves diastolic and systolic function in failing human myocardium.
|
Eur J Pharmacol
|
2000
|
0.83
|
46
|
Pharmacokinetics of hydrochlorothiazide in relation to renal function.
|
Eur J Clin Pharmacol
|
1983
|
0.83
|
47
|
Calcium pump overexpression and myocardial function. Implications for gene therapy of myocardial failure.
|
Circ Res
|
1998
|
0.83
|
48
|
Frequency-dependent changes in contribution of SR Ca2+ to Ca2+ transients in failing human myocardium assessed with ryanodine.
|
J Mol Cell Cardiol
|
1998
|
0.83
|
49
|
Influence of cardiac function on the diuretic and hemodynamic effects of the loop diuretic piretanide.
|
Clin Cardiol
|
1987
|
0.81
|
50
|
Influence of forskolin on the force-frequency behavior in nonfailing and end-stage failing human myocardium.
|
Basic Res Cardiol
|
1998
|
0.81
|
51
|
Ca(2+)-dependent and Ca(2+)-independent regulation of contractility in isolated human myocardium.
|
Basic Res Cardiol
|
1997
|
0.80
|
52
|
Unaltered ryanodine receptor protein levels in ischemic cardiomyopathy.
|
Mol Cell Biochem
|
1997
|
0.80
|
53
|
Increased basal contractility of cardiomyocytes overexpressing protein kinase C epsilon and blunted positive inotropic response to endothelin-1.
|
Cardiovasc Res
|
2001
|
0.80
|
54
|
Influence of SR Ca(2+)-ATPase and Na(+)-Ca(2+)-exchanger on the force-frequency relation.
|
Basic Res Cardiol
|
1998
|
0.80
|
55
|
Positive and negative inotropic effects of DL-sotalol and D-sotalol in failing and nonfailing human myocardium under physiological experimental conditions.
|
Circulation
|
1995
|
0.79
|
56
|
[A 17-year-old with cardiac mass and pulmonary embolism].
|
Internist (Berl)
|
2009
|
0.79
|
57
|
Increased proatherogenic monocyte-platelet cross-talk in monocyte subpopulations of patients with stable coronary artery disease.
|
J Intern Med
|
2013
|
0.79
|
58
|
Influence of the positive inotropic substance pimobendan (UD-CG 115 BS) on contractile economy of guinea pig papillary muscles.
|
J Cardiovasc Pharmacol
|
1989
|
0.79
|
59
|
[Differential therapy of heart failure. Which drug for which patient?].
|
Internist (Berl)
|
2004
|
0.78
|
60
|
Protective role of nebivolol in hydroxyl radical induced injury.
|
J Cardiovasc Pharmacol
|
2001
|
0.78
|
61
|
Preservation of myocardial function after adenoviral gene transfer in isolated myocardium.
|
Am J Physiol Heart Circ Physiol
|
2000
|
0.78
|
62
|
Acute and chronic changes of myocardial energetics in the mammalian and human heart.
|
Basic Res Cardiol
|
1987
|
0.78
|
63
|
Load-induced cardiomyocyte apoptosis in cultured multicellular myocardial preparations is unaltered in presence of the beta-adrenoceptor antagonist nebivolol.
|
Pharmacology
|
2008
|
0.78
|
64
|
Repeat determination of left ventricular wall thickness from mass and volume during one cardiac cycle for the calculation of left ventricular wall stress parameters.
|
Clin Cardiol
|
1990
|
0.78
|
65
|
Myothermal economy of rat myocardium, chronic adaptation versus acute inotropism.
|
Basic Res Cardiol
|
1986
|
0.78
|
66
|
Ca2+ sensitization in idiopathic dilated human myocardium. Differential in vitro effects of (+)-(5-methyl-6-phenyl)-1,3,5,6-tetrahydro-3,6-methano-1,5-benzodiazoci ne-2,4-dione, a novel purely Ca2+sensitizing agent, and (+)-5-(1-(3,4-dimethoxybenzoyl)-1,2,3,4-tetrahydroquinolin-6-yl)-6-meth yl-3, 6-dihydro-2H-1,3,4-thiadiazin-2-one on skinned fibres and isolated ventricular strips.
|
Arzneimittelforschung
|
1996
|
0.77
|
67
|
Impact of beta-adrenoceptor antagonists on myofilament calcium sensitivity of rabbit and human myocardium.
|
J Cardiovasc Pharmacol
|
2000
|
0.77
|
68
|
The reorganization of the human and rabbit heart in response to haemodynamic overload.
|
Eur Heart J
|
1992
|
0.77
|
69
|
The effect of the partial beta-1-adrenoceptor agonist xamoterol on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.
|
J Cardiovasc Pharmacol
|
1991
|
0.77
|
70
|
Cardiac and hemodynamic effects of the sinus node inhibitor tedisamil dihydrochloride in patients with congestive heart failure due to dilated cardiomyopathy.
|
J Cardiovasc Pharmacol
|
1998
|
0.76
|
71
|
[Efficacy of a cognitive-behavioral program with pharmacological support to achieve smoking cessation].
|
Dtsch Med Wochenschr
|
2006
|
0.76
|
72
|
Positive inotropism and myocardial energetics: influence of beta receptor agonist stimulation, phosphodiesterase inhibition, and ouabain.
|
Cardiovasc Res
|
1994
|
0.76
|
73
|
Functional significance of angiotensin receptors in human myocardium. Significant differences between atrial and ventricular myocardium.
|
Eur Heart J
|
1994
|
0.76
|
74
|
The functional effect of adenoviral Na+/Ca2+ exchanger overexpression in rabbit myocytes depends on the activity of the Na+/K+-ATPase.
|
Cardiovasc Res
|
2003
|
0.76
|
75
|
[Pathophysiological basis of heart failure].
|
Ther Umsch
|
2000
|
0.76
|
76
|
Cardiac changes in diabetes.
|
Exp Clin Endocrinol Diabetes
|
1995
|
0.75
|
77
|
Separation between vasodilation and positive inotropism by assessment of myocardial energetics in patients with dilated cardiomyopathy.
|
Basic Res Cardiol
|
1989
|
0.75
|
78
|
Hemodynamics and myocardial oxygen metabolism of pulsus alternans in patients with dilative cardiomyopathy.
|
Clin Cardiol
|
1987
|
0.75
|
79
|
Assessment of myocardial function by calculation of two energetic parameters from pressure-volume relations and wall thickness in human ventricles.
|
Clin Cardiol
|
1986
|
0.75
|
80
|
Independent of etozolin elimination of kidney function. Single dose experiments in patients with renal insufficiency.
|
Arzneimittelforschung
|
1980
|
0.75
|
81
|
Influence of enoximone on mechanics and energetics of right ventricular guinea pig papillary muscles.
|
J Cardiovasc Pharmacol
|
1989
|
0.75
|
82
|
[Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone].
|
Z Kardiol
|
1991
|
0.75
|
83
|
Myocardial performance and efficiency as assessed by energetic parameters derived from pressure-volume relations and wall thickness in human ventricles.
|
Z Kardiol
|
1986
|
0.75
|
84
|
Influence of enoximone and UDCG-115 on coronary hemodynamics in idiopathic dilated cardiomyopathy.
|
Am J Cardiol
|
1988
|
0.75
|
85
|
Myocyte reorganization in hypertrophied and failing hearts.
|
Eur Heart J
|
1995
|
0.75
|
86
|
Signaling pathways in failing human heart muscle cells.
|
Trends Cardiovasc Med
|
1997
|
0.75
|
87
|
[Induced platelet aggregation in patients with coronary heart disease as well as trained and untrained control persons].
|
Z Kardiol
|
1985
|
0.75
|
88
|
[Immunsuppressive therapy in virus-negative eosinophilic inflammatory cardiomyopathy].
|
Dtsch Med Wochenschr
|
2011
|
0.75
|
89
|
Left ventricular geometry, myocardial function and energetics of the dilated left ventricle. Influence of vasodilators and positive inotropic substances.
|
Herz
|
1991
|
0.75
|
90
|
Cellular and molecular alterations in the failing human heart.
|
Basic Res Cardiol
|
1992
|
0.75
|
91
|
[Symptoms of primary endocardial fibroelastosis in a young adult].
|
Dtsch Med Wochenschr
|
2001
|
0.75
|
92
|
Atheroprotective Krüppel-like factor 4 is downregulated in monocyte subsets of patients with coronary artery disease.
|
Thromb Haemost
|
2013
|
0.75
|
93
|
The heart in heart failure. Ventricular and myocardial alterations.
|
Eur Heart J
|
1991
|
0.75
|
94
|
The regulation of calcium cycling in stressed hearts.
|
Basic Res Cardiol
|
1992
|
0.75
|
95
|
Pharmacokinetics of carteolol in relation to renal function.
|
Eur J Clin Pharmacol
|
1985
|
0.75
|
96
|
A mechanistic analysis of reduced mechanical performance in human heart failure.
|
Jpn Heart J
|
2000
|
0.75
|
97
|
[Heart failure - a scientific and clinical challenge].
|
Dtsch Med Wochenschr
|
2011
|
0.75
|
98
|
[Heart failure - deliberate diagnosis of various causes or only diagnostic and therapeutic endpoints?].
|
Herz
|
2011
|
0.75
|
99
|
Catecholamine metabolism in heart failure patients and healthy control subjects.
|
Arzneimittelforschung
|
1990
|
0.75
|
100
|
Energetic consequences of substances currently used or recommended for long-term treatment of chronic heart failure.
|
Basic Res Cardiol
|
1991
|
0.75
|
101
|
[Successful treatment of fulminant myocarditis with the biventricular MEDOS Assist System (MEDOS HIA-VAD)].
|
Z Kardiol
|
1997
|
0.75
|
102
|
Optimization of myocardial function.
|
Basic Res Cardiol
|
1993
|
0.75
|
103
|
[Optimization of diuretic therapy in heart failure].
|
Verh Dtsch Ges Inn Med
|
1985
|
0.75
|
104
|
[Commentary on the 2010 ESC guidelines on device therapy in heart failure ].
|
Herzschrittmacherther Elektrophysiol
|
2012
|
0.75
|
105
|
Energetic consequences of positive inotropic interventions in guinea pig papillary muscles.
|
Prog Clin Biol Res
|
1989
|
0.75
|
106
|
Catecholamine metabolism in patients with congestive heart failure under acute and chronic oral levodopa therapy.
|
Arzneimittelforschung
|
1990
|
0.75
|
107
|
Contraction frequency dependence of twitch and diastolic tension in human dilated cardiomyopathy (tension-frequency relation in cardiomyopathy).
|
Basic Res Cardiol
|
1992
|
0.75
|
108
|
Acute effects of nitrates on left ventricular performance and energetics.
|
Z Kardiol
|
1986
|
0.75
|
109
|
[Acute effects of nitroglycerin on the energetics of the human left ventricular myocardium].
|
Z Kardiol
|
1987
|
0.75
|
110
|
Images in cardiology: treatment of tachyarrhythmia induced syncopes by angioplasty of the right coronary artery.
|
Heart
|
2000
|
0.75
|
111
|
[Acute cor pulmonale in pulmonary embolism. An important prognostic factor and a critical parameter for the choice of a therapeutic strategy].
|
Internist (Berl)
|
2004
|
0.75
|
112
|
Pathophysiology and treatment of congestive heart failure.
|
Cardiology
|
1994
|
0.75
|
113
|
International Gargellen Conference.
|
Circulation
|
1997
|
0.75
|
114
|
Cardiac energetics after intravenous enoximone in idiopathic dilated cardiomyopathy.
|
Am J Cardiol
|
1987
|
0.75
|
115
|
Myocardial energetics in dilated cardiomyopathy.
|
Clin Cardiol
|
1990
|
0.75
|
116
|
[Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].
|
Med Klin (Munich)
|
1994
|
0.75
|
117
|
[Use of enoximone in patients with acute and subacute heart failure in the intensive care unit].
|
Z Kardiol
|
1994
|
0.75
|